# FDA recall D-0006-2017

> **Shire** · Class III · drug recall initiated 2016-09-02.

## Product

Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10

## Reason for recall

Presence of Foreign Tablets/Capsules

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0006-2017
- **Recalling firm:** Shire
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-09-02
- **Report date:** 2016-10-12
- **Termination date:** 2019-03-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Chesterbrook, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0006-2017

## Citation

> AI Analytics. FDA recall D-0006-2017. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0006-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*